These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 32516308)

  • 1. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
    Bandy A; Almaeen AH
    PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.
    Zhang HM; Liu DW; Wang XT; Long Y; Chen H
    Chin Med Sci J; 2014 Mar; 29(1):51-4. PubMed ID: 24698680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.
    Perez F; Endimiani A; Ray AJ; Decker BK; Wallace CJ; Hujer KM; Ecker DJ; Adams MD; Toltzis P; Dul MJ; Windau A; Bajaksouzian S; Jacobs MR; Salata RA; Bonomo RA
    J Antimicrob Chemother; 2010 Aug; 65(8):1807-18. PubMed ID: 20513702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance patterns of Gram-negative bacteria isolated from bloodstream infections in an Iranian referral paediatric hospital: A 5.5-year study.
    Mahmoudi S; Mahzari M; Banar M; Pourakbari B; Haghi Ashtiani MT; Mohammadi M; Keshavarz Valian S; Mamishi S
    J Glob Antimicrob Resist; 2017 Dec; 11():17-22. PubMed ID: 28729206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antibiotic resistance profiles of Gram negative bacilli associated with urinary tract infections (UTIs) in Karachi, Pakistan.
    Rasool MS; Siddiqui F; Ajaz M; Rasool SA
    Pak J Pharm Sci; 2019 Nov; 32(6):2617-2623. PubMed ID: 31969294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection models.
    Frimodt-Møller N; Hansen JU; Plattner M; Huseby DL; Radmer Almind S; Haldimann K; Gysin M; Petersson A; Ercan O; Ganz L; Hughes D; Vingsbo Lundberg C; Hobbie SN
    Int J Antimicrob Agents; 2024 Jul; 64(1):107181. PubMed ID: 38653351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H; Yang Q; Liao K; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Chu Y; Chen S; Cao B; Su J; Duan Q; Zhang S; Shao H; Kong H; Gui B; Hu Z; Badal R; Xu Y
    BMC Infect Dis; 2017 Dec; 17(1):776. PubMed ID: 29254478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Blood Culture Isolates and their Antibiogram in a Teaching hospital.
    Shrestha S; Amatya R; Shrestha RK; Shrestha R
    JNMA J Nepal Med Assoc; 2014; 52(193):692-6. PubMed ID: 26905550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trends in antimicrobial resistance of ESKAPEEc pathogens from bloodstream infections - Experience of a tertiary care centre in North India.
    Gupta M; Gupta V; Gupta R; Chaudhary J
    Indian J Med Microbiol; 2024; 50():100647. PubMed ID: 38871082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
    Beshah D; Desta AF; Woldemichael GB; Belachew EB; Derese SG; Zelelie TZ; Desalegn Z; Tessema TS; Gebreselasie S; Abebe T
    PLoS One; 2023; 18(6):e0287453. PubMed ID: 37368908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
    De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
    Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    Budak S; Oncul O; Aktas Z; Acar A; Ozyurt M; Turhan V; Erdem H; Gorenek L
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):113-22. PubMed ID: 24964660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
    Meletis G; Oustas E; Botziori C; Kakasi E; Koteli A
    New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Urban C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2732-4. PubMed ID: 20368401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.